US 11304926
Application of transient receptor potential cation channel TRPV3 in developing drug for preventing or treating psoriasis
granted A61KA61K31/352A61K45/00
Quick answer
US patent 11304926 (Application of transient receptor potential cation channel TRPV3 in developing drug for preventing or treating psoriasis) held by CHINA PHARMACEUTICAL UNIVERSITY expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CHINA PHARMACEUTICAL UNIVERSITY
- Grant date
- Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/352, A61K45/00, A61P, A61P17/06